Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure

Cardiovascular Drugs and Therapy

Volumn 19, Issue 4, 2005, Pages 261-265

  MacIntrye, Iain M ^a   Jhund, Pardeep S ^a   McMurray, John J V ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Angiotensin converting enzyme inhibitors; Aspirin; Heart failure; Vasodilation

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL;

ADULT; AGED; ARTICLE; CAPACITANCE BLOOD VESSEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ANTAGONISM; FOREARM BLOOD FLOW; HEART FAILURE; HEART RATE; HEMODYNAMICS; HUMAN; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASODILATATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CAPTOPRIL; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FIBRINOLYTIC AGENTS; FOREARM; HEART FAILURE, CONGESTIVE; HUMANS; PLATELET AGGREGATION INHIBITORS; PLETHYSMOGRAPHY; VASODILATION; VEINS;

EID: 28844492097     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-005-3309-3     Document Type: Article

References (26)

1. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure: Relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med 1984;310:347-352.
2. Townend JN, Doran J, Lote CJ, Davies MK. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril. Br Heart J 1995;73:434-441.
3. Nishimura H, Kubo S, Ueyama M, Kuboto J, Kawamura K. Perripheral hemodynamic effects of captopril in patients with congestive heart failure. Am Heart J 1989;117:100-105.
4. Hall D, Zeitler H, Rudolf W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992;20:1549-1555.
5. Antiplatelet trialists' collaboration. Collaborative overview of randomized trials of antiplatelet therapy. Part I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patient. Br Med J 1994;308:81-106.
6. Cleland JG, Bulpitt CJ, Falk RH, et al. Is aspirin safe for patients with heart failure? Br Heart J 1995;74:215-219.
7. Nguyen KN, Aursnes I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Am J Cardiol 1997;79:115-119.
8. Takkouche B, Etminan M, Caamano F, Rochon PA. Interaction between aspirin and ACE Inhibitors: Resolving discrepancies using a meta-analysis. Drug Saf 2002;25:373-378.
9. Meune C, Mourad JJ, Bergmann JF, Spaulding C. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: Rationale and clinical relevance. J Renin Angiotensin Aldosterone Syst 2003;4:149-154.
10. Peterson JG, Topol EJ, Sapp SK, Young JB, Lincoff AM, Lauer MS. Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. Am J Med 2000;109:371-377.
11. Latini R, Tognoni G, Maggioni AP, et al. Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of Aspirin: Systematic overview of individual data from 96712 randomized patietns. Angiotensin- converting Enzyme Inhibitor Myocardial Infarction Collaborative Group. J Am Coll Cardiol 2000;35:1801-1807.
12. Leor J, Reicher-Reiss H, Goldbourt U, et al. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: A cohort study of 11575 patients with coronary artery disease. J Am Coll Cardiol 1999;33:1920-1925.
13. Teo KK, Yusuf S, Pfeffer M, et al. ACE Inhibitors Collaborative Group: Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: A systematic review. Lancet 2002;360:1037-1043.
14. Spaulding C, Charbonnier B, Cohen-Solal A, et al. Acute hemodynamic interaction of aspirin and ticlodipine with enalapril. Circulation 1998;98:757-765.
15. Jhund PS, Davie AP, McMurray JJV. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol 2001;37:1234-1238.
16. Capewell S, Taverner D, Hannan WJ, Muir AL. Acute and chronic arterial and venous effects of captopril in congestive cardiac failure. Br Med J 1989;299;942-945.
17. Preston FE, Greaves M, Jackson CA, Stoddard CJ. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man. Thromb Res 1982;27:477-484.
18. Fisman EZ, Grossman E, Motro M, Tenenbaum A. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002;16:379-383.
19. Katz SD, Radin M, Graves T, Hauck C, Block A, LeJemtel TH. Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with Enalapril: Ifetroban Study Group. J Am Coll Cardiol 1999;34:170-176.
20. van Wijngaarden J, Smit AJ, de Graeff PA, et al. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994;23:240-245.
21. Meune C, Mahe I, Mourad J, et al. Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: A dose-mediated deleterious effect. Eur J Heart Fail 2003;5:271-279.
22. Galatius S, Wroblewski H, Kastrup J. Does aspirin treatment influence vascular resistance and fluid filtration in patients with congestive heart failure. Heart 1999;81:330.
23. Davie AP, Love MP, McMurray JJ. Even low-dose aspirin inhibtis arachidonic acid-induced vasodilation in heart failure. Clin Pharmacol Ther 2000;67:530-537.
24. Benjamin N, Calver A, Collier JG, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-923.
25. Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart Failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004;148:157-164.
26. Masse BM, Kcol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): Rationale, design, and baseline patient characteristics. J Card Fail 2004;10:101-112.